Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA Advisory Committee discusses liraglutide for the treatment of type 2 diabetes

April 7, 2009

New compounds for the treatment of diabetes reported by Boehringer Ingelheim

April 7, 2009

Low-molecular-weight allosteric inhibitor of luteinizing hormone receptor identified

April 6, 2009

Novel mu-opioid receptor ligands developed by OSI Prosidion for the treatment of obesity

April 6, 2009

Novel bile acid responsive receptor ligands discovered by Kalypsus

April 6, 2009

Enrollment completed in Depomed's phase III trial of Serada in menopausal hot flashes

April 6, 2009

Shanghai Hengrui discloses dipeptidyl peptidase IV inhibitors for diabetes

April 6, 2009

FDA Advisory Committee finds Onglyza cardiovascular risk profile acceptable

April 3, 2009

FDA accepts for filing Xanodyne's NDA for menorrhagia treatment

April 3, 2009

Strativa acquires worldwide rights to Nascobal nasal spray from QOL

April 3, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...